Erica Sessle

Chief Executive Officer at Lifelong

Erica Sessle has an extensive work experience history in various organizations. Erica currently holds the position of Chief Executive Officer at Lifelong, starting in June 2022. Prior to that, they worked as a Principal at Gryphon Consulting since June 2021.

From September 2017 to October 2021, Erica served as the Chief of Staff at PATH, and from October 2015 to September 2017, they held the same position at the Allen Institute for Brain Science.

Erica also has experience working with the U.S. Department of State as the PEPFAR Director of Country Oversight and Accountability in the Office of the Global AIDS Coordinator from March 2014 to October 2015.

Before joining the government, they held leadership roles at the Fred Hutchinson Cancer Research Center. This includes serving as the Vice-President and Chief Operating Officer of the Hutchinson Center Research Institute of Uganda from March 2009 to March 2014, and as the Managing Director of the Program in Global Oncology from March 2006 to March 2014.

Additionally, Erica has experience as a Senior Clinical Research Associate at Dendreon from February 2005 to March 2006, and as the Manager of the Statistical Center for HIV/AIDS Research and Prevention at the Fred Hutchinson Cancer Research Center from January 2004 to February 2005.

Erica'searliest work experience includes coordinating and being a principal investigator at the MU-JHU Research Collaboration and Johns Hopkins University School of Medicine from 1999 to 2003.

Erica Sessle's education history is as follows:

From 2012 to 2013, they attended Harvard Business School and completed a Program in Leadership Development.

In 2006 to 2007, they studied at the University of Washington and obtained a Project Management certificate.

From 2000 to 2003, they attended the Johns Hopkins Bloomberg School of Public Health and earned a Master of Public Health (MPH) degree with a focus on Epidemiology.

In 1995 to 1996, they studied at the University of Cambridge and obtained a Master of Philosophy (MPhil) degree in English.

From 1991 to 1995, they attended the University of Toronto - Victoria University and graduated with a Bachelor of Arts (BA) degree. The field of study for their BA degree is not specified.

Links

Previous companies

Allen Institute logo
PATH logo
Dendreon Pharmaceuticals, Inc. logo

Org chart

Timeline

  • Chief Executive Officer

    June, 2022 - present